Mucolysin (Acetylcysteine)

Acetylcysteine, the active ingredient in Mucolysin, is a mucolytic presented as an oral formulation for oral use. It reduces mucus thickness and is employed in chronic respiratory conditions such as chronic bronchitis and COPD.

GNH USA supplies Mucolysin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mucolysin is a mucolytic that acts on the respiratory tract to improve mucus clearance in several chronic lung diseases.

Chronic bronchitis: helps loosen and clear thick bronchial secretions, easing cough and airflow obstruction. COPD: reduces mucus viscosity, supporting better ventilation and symptom control. Acute respiratory tract infections: facilitates expectoration of sputum, aiding recovery and comfort.

Acetylcysteine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea or upset stomach - Vomiting - Diarrhea - Mild skin rash or itching - Metallic taste in the mouth - Headache

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, angioedema) - Bronchospasm, especially in asthmatic patients - Hepatic dysfunction (elevated liver enzymes) - Hemolysis in patients with G6PD deficiency - Persistent vomiting leading to dehydration

Before using Mucolysin, consider the following safety measures.

Pregnancy: consult a healthcare professional as safety data are limited. Breastfeeding: discuss potential risks with a physician. Renal impairment: dose adjustment may be required. Asthma: monitor closely for bronchospasm after administration. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Acetylcysteine may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Nitroglycerin: concurrent use can cause profound hypotension.

Moderate Interactions (Monitor Closely): - Warfarin or other anticoagulants: may enhance anticoagulant effect, increasing bleeding risk. - Carbapenem antibiotics (e.g., imipenem): higher incidence of rash. - Bronchodilators (e.g., beta‑agonists): watch for bronchospasm. - Alcohol: may increase gastrointestinal irritation.